This site is intended for healthcare professionals only
LoginRegister
Despite SC, NMC orders, rabies immunoglobulin missing in major BMC hospitalsBlacklisted Gujarat Pharma Firm's Injection Causes Memory Loss in Pregnant Women
Doctor, retired police officer duped of Rs 1.44 crore in fake investment schemePharma Scam worth Rs 10 Cr in Ludhiana: Company Employees Booked for Massive Internal Fraud
From Teriparatide to Pembrolizumab: CDSCO Clears Import of r-DNA Drugs via CT-18 RouteUSFDA plans to phase out animal testing requirement for monoclonal antibodies, other drugs
USFDA Grants Tentative Approval, 180-Day Exclusivity to Granules Generic Amphetamine XRGranules India successfully closes acquisition of Swiss based CDMO Senn Chemicals
USFDA Approves Bionpharmas Generic HIV Drug EtravirineBiocon arm secures USFDA approval for Everolimus Tablets for prophylaxis of organ rejection in adult...
Cipla to Recall Lanreotide Injection in US, Temporary Supply Disruption ExpectedCipla gets USFDA nod for Paclitaxel Protein bound Particles for Injectable Suspension
Johnson and Johnson Agrees to Cut US Drug Prices in Deal with Trump Administration to Avoid TariffsJnJ gets European Commission nod for subcutaneous Darzalex-based quadruplet regimen for newly...
Intas PharmaIntas Pharmaceutical Gets CDSCO Panel Nod To Conduct Phase III clinical trial of Fibrogen-I
Revise Phase III Trial Protocol for Roflumilast Cream: CDSCO Panel Tells Sun PharmaCourt Removes Injunction on Sun Pharma's LEQSELVI Launch in US
CDSCO Panel Accepts Glenmarks Apremilast Trial Report, Seeks 2-Year PSUR DataGlenmark gets CDSCO Panel nod to study Glycopyrronium, Fluticasone Furoate, Vilanterol Powder for...
Sanofi India Rodolfo Hrosz resigns as MDSanofi India Rodolfo Hrosz resigns as MD
Cipla Recalls Cancer Drug Nilotinib in US Over Manufacturing IssueBiocon, Glenmark recall anxiety, high cholesterol medications in US
X